BioVie Inc(BIVI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BIVI BioVie Inc

Market Closed 11-06 16:00:00 EST

1.33

+0.12

+9.92%

盘后1.28

-0.05-3.74%

19:55 EST

High1.38	Low1.23	Vol184.39K
Open1.25	D1 Closing1.21	Amplitude12.39%
Mkt Cap11.55M	Tradable Cap11.46M	Total Shares8.68M
T/O243.93K	T/O Rate2.14%	Tradable Shares8.62M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BIVI","market":"US","secType":"STK","nameCN":"BioVie Inc","latestPrice":1.33,"timestamp":1793998800000,"preClose":1.21,"halted":0,"volume":184386,"hourTrading":{"tag":"盘后","latestPrice":1.2803,"preClose":1.33,"latestTime":"19:55 EST","volume":10315,"amount":13398.7649,"timestamp":1794012929016,"change":-0.0497,"changeRate":-0.037368,"amplitude":0.037368},"delay":0,"changeRate":0.09917355371900835,"floatShares":8618000,"shares":8682700,"eps":-3.049999,"marketStatus":"Market Closed","change":0.12,"latestTime":"11-06 16:00:00 EST","open":1.25,"high":1.38,"low":1.2301,"amount":243930.2135064,"amplitude":0.123884,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.049999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.21,"preHourTrading":{"tag":"盘前","latestPrice":1.23,"preClose":1.21,"latestTime":"09:04 EST","volume":871,"amount":1086.2440459,"timestamp":1793973857595,"change":0.02,"changeRate":0.016529,"amplitude":0.107521},"postHourTrading":{"tag":"盘后","latestPrice":1.2803,"preClose":1.33,"latestTime":"19:55 EST","volume":10315,"amount":13398.7649,"timestamp":1794012929016,"change":-0.0497,"changeRate":-0.037368,"amplitude":0.037368},"volumeRatio":0.060074691149697386,"impliedVol":1.6378,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BIVI","defaultTab":"news","newsList":[{"id":"2680051963","title":"BioVie Prices $4.74 Million Registered Direct Offering at $1.60 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2680051963","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680051963?lang=en_us&edition=fundamental","pubTime":"2026-11-04 21:04","pubTimestamp":1793797499,"startTime":"0","endTime":"0","summary":"BioVie Prices $4.74 Million Registered Direct Offering at $1.60 a ShareBioVie priced a $4.74 million registered direct offering of 2,962,500 common shares or common stock equivalents at $1.60 each.A c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL2Bw8tX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4585","SG9999014013.SGD","SG9999014039.USD","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","BIVI","SG9999014021.USD","BK4112","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4588","BCDF","IE00BGHQF748.EUR","BK4139","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680051350","title":"Press Release: BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under NASDAQ Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2680051350","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680051350?lang=en_us&edition=fundamental","pubTime":"2026-11-04 21:00","pubTimestamp":1793797200,"startTime":"0","endTime":"0","summary":"CARSON CITY, Nev., Nov. 04, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (\"BioVie\" or the \"Company\"), a clinical-stage company developing innovative drug therapies for neurological and neurodeg","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","NQmain","BIVI","QQQY","QQQE","QLD","IYW","QYLG","QQQM","TECS","QQQJ","BK4139","NDX","PSQ","QQQA","FTEC","03086","TQQQ","ONEQ","QDTE","MNQmain","JEPQ","TQQY","QQQ","QID","GPIQ",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680736357","title":"NASDAQ Trade Halt Volatility Trading Pause at 11:12 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2680736357","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680736357?lang=en_us&edition=fundamental","pubTime":"2026-11-04 00:12","pubTimestamp":1793722342,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 11:12 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nAQN2MRU7Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680763367","title":"BioVie to Present New Biomarker Data from Phase 2 Bezisterim Long COVID Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2680763367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680763367?lang=en_us&edition=fundamental","pubTime":"2026-11-02 22:08","pubTimestamp":1793628519,"startTime":"0","endTime":"0","summary":"BioVie to present new biomarker data from Phase 2 bezisterim Long COVID trialBioVie will present Phase 2 bezisterim Long COVID findings, including previously undisclosed biomarker data, on November 13","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nNDLbxHM3W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2095319765.USD","SG9999014005.SGD","BK4585","BK4588","SG9999014013.SGD","IE00BQXX3C00.GBP","NDAQ","IE00BN0W2W23.USD","LU2210150020.SGD","BK4139","SG9999014021.USD","IE00BN0W2V16.EUR","BCDF","IE00BQXX3D17.EUR","LU0314104364.USD","BIVI","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678198711","title":"BioVie’s Bezisterim Shows Trend Toward Symptom Improvement in Phase 2 Long COVID Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2678198711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678198711?lang=en_us&edition=fundamental","pubTime":"2026-10-26 20:10","pubTimestamp":1793016647,"startTime":"0","endTime":"0","summary":"BioVie’s Bezisterim Shows Trend Toward Symptom Improvement in Phase 2 Long COVID TrialBioVie will present Phase 2 ADDRESS-LC results for bezisterim in Long COVID on November 5, 2026, at the RECOVER-TL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nNDLc5Mxdd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU2210150020.SGD","BK4588","IE00BQXX3D17.EUR","BK4112","LU0314104364.USD","BCDF","BIVI","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BQXX3F31.USD","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","BK4585","LU2095319765.USD","BK4139","IE00BKPKM429.USD","SG9999014021.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678235198","title":"BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop","url":"https://stock-news.laohu8.com/highlight/detail?id=2678235198","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678235198?lang=en_us&edition=fundamental","pubTime":"2026-10-26 20:00","pubTimestamp":1793016000,"startTime":"0","endTime":"0","summary":"CARSON CITY, Nev., Oct.  26, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurode","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/26/3388041/0/en/biovie-invited-to-present-data-on-bezisterim-in-long-covid-at-the-nih-s-recover-tlc-third-annual-workshop.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PD","LU1169590202.USD","LU1169589451.USD","BK4132","AD","BIVI","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676704693","title":"BioVie presents results from SUNRISE-PD clinical trial evaluating bezisterim","url":"https://stock-news.laohu8.com/highlight/detail?id=2676704693","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676704693?lang=en_us&edition=fundamental","pubTime":"2026-10-20 20:16","pubTimestamp":1792498562,"startTime":"0","endTime":"0","summary":"BioVie (BIVI) announced the presentation of results from the Phase 2 SUNRISE-PD clinical trial evaluating bezisterim in early Parkinson’s patients ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biovie-presents-results-from-sunrise-pd-clinical-trial-evaluating-bezisterim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biovie-presents-results-from-sunrise-pd-clinical-trial-evaluating-bezisterim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIVI","MEDX","IDNA","BK4139","GDOC","HYLG","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676195693","title":"BioVie’s Bezisterim Improves Parkinson’s Symptoms in Patients with Elevated Inflammation in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2676195693","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676195693?lang=en_us&edition=fundamental","pubTime":"2026-10-20 20:11","pubTimestamp":1792498301,"startTime":"0","endTime":"0","summary":"BioVie’s Bezisterim improves Parkinson’s symptoms in patients with elevated inflammation in Phase 2 trialBioVie presented Phase 2 SUNRISE-PD results for bezisterim in early Parkinson’s disease at the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDLvBvPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BK4112","BK4139","NDAQ","LU2210149790.SGD","SG9999014039.USD","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","LU2210150020.SGD","BK4588","BIVI","IE00BN0W2W23.USD","SG9999014021.USD","BCDF","BK4585","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676689136","title":"BioVie presents Phase 2 data on bezisterim in Long COVID","url":"https://stock-news.laohu8.com/highlight/detail?id=2676689136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676689136?lang=en_us&edition=fundamental","pubTime":"2026-10-19 21:20","pubTimestamp":1792416038,"startTime":"0","endTime":"0","summary":"BioVie (BIVI) announced the presentation of results from the Phase 2 ADDRESS-LC study evaluating bezisterim in patients with Long COVID at the 151s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biovie-presents-phase-2-data-on-bezisterim-in-long-covid-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biovie-presents-phase-2-data-on-bezisterim-in-long-covid-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676685349","title":"BioVie’s Bezisterim Improves Fatigue in More Severely Affected Long COVID Patients in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2676685349","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676685349?lang=en_us&edition=fundamental","pubTime":"2026-10-19 20:09","pubTimestamp":1792411740,"startTime":"0","endTime":"0","summary":"BioVie’s Bezisterim Improves Fatigue in More Severely Affected Long COVID Patients in Phase 2 TrialBioVie presented Phase 2 ADDRESS-LC results for bezisterim in Long COVID at the American Neurological","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nNDLc9bYcT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NDAQ","SG9999014005.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014013.SGD","BK4112","IE00BQXX3C00.GBP","BK4139","BIVI","BK4585","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","LU0314104364.USD","IE00BKPKM429.USD","SG9999014021.USD","IE00BQXX3F31.USD","BK4588","BCDF","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676683005","title":"BioVie Presents Data on Bezisterim in Long COVID at the 2026 American Neurological Association Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2676683005","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676683005?lang=en_us&edition=fundamental","pubTime":"2026-10-19 20:00","pubTimestamp":1792411200,"startTime":"0","endTime":"0","summary":"Phase 2 data from the ADDRESS-LC trial of Bezisterim demonstrated statistically significant improvements versus placebo across fatigue, post-exertional malaise, and objective cognitive measures in Lon","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/19/3383392/0/en/biovie-presents-data-on-bezisterim-in-long-covid-at-the-2026-american-neurological-association-annual-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","LU1169589451.USD","BK4132","BIVI","AD","BK4107","LU1169590202.USD","BK4023","PD","BK4117","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675341378","title":"BioVie to Present Phase 2 Bezisterim Long COVID Trial Results at ANA 2026 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2675341378","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675341378?lang=en_us&edition=fundamental","pubTime":"2026-10-14 20:03","pubTimestamp":1791979419,"startTime":"0","endTime":"0","summary":"BioVie to present Phase 2 bezisterim Long COVID trial results at ANA 2026 meetingBioVie flagged new Phase 2 findings for bezisterim in Long COVID, set for poster presentation at ANA2026 on Oct. 18.The","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nNDL2k8dvT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","BK4139","SG9999014013.SGD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","BIVI","BK4585","IE00BN0W2V16.EUR","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014005.SGD","BK4112","IE00BKPKM429.USD","BCDF","LU2210149790.SGD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4588","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675602341","title":"BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2675602341","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675602341?lang=en_us&edition=fundamental","pubTime":"2026-10-14 20:00","pubTimestamp":1791979200,"startTime":"0","endTime":"0","summary":"CARSON CITY, Nev., Oct.  14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurode","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/14/3380674/0/en/biovie-to-present-new-bezisterim-findings-in-parkinson-s-disease-and-long-covid-at-the-2026-american-neurological-association-annual-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU1169590202.USD","BK4117","BK4132","BK4107","AD","PD","AFG","BIVI","BK4139","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667862671","title":"U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2667862671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667862671?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:53","pubTimestamp":1789491227,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells FargoSeptember 15 (Reuters)-Wall Street's main indexes slipped on Tuesday, dragged down by higher crude prices, elevated Treasury yields","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","CONL","LLII","VRA","WFC","WGMI","09311","VERA","ICOI","PEJ","COIO","PDM","HRTS","09711","BIVI","HUT","RIVN","IMRA","IYF","LLYZ","COIN","DAPP","OTIS","XLV","RVNL","CANC","07711","KBWB","MEMS","FPS","COII","BITQ","LEGN","OWNB","MARA","PLAY","SYY","RIOT","CRPT","PJP","CNTB","TRUH","WAY","RXL","GDOC","THNR","MRAL","LLY","LFGY","AXON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642226","title":"BioVie Falls After Long COVID Drug Fails to Show Benefit in Overall Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642226","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642226?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:33","pubTimestamp":1789475616,"startTime":"0","endTime":"0","summary":"BUZZ-BioVie falls after long COVID drug fails to show benefit in overall trial** Shares of drug developer BioVieBIVI.Ofall 10.7% to $1.83 premarket** Company says its experimental oral drug bezisterim did not reach statistical significance on any of the 22 measures in a mid-stage trial that enrolled 203 patients with long COVID** Long COVID can cause symptoms that persist after the initial COVID-19 infection, including fatigue, difficulty thinking, sleep problems and worsening symptoms after physical or mental activity** Results on 21 measures favored the drug, but significant benefits were limited to pre-specified groups with more severe fatigue, thinking problems or worsening symptoms after activity - BIVI** Patients in these groups accounted for about 78% of trial participants; company says subgroup findings were exploratory and need confirmation in a larger late-stage trial** Safety was similar to placebo, with no serious side effects reported among patients receiving bezisterim** ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644310","title":"BioVie announces topline results from ADDRESS-LC trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644310","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644310?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:40","pubTimestamp":1789472425,"startTime":"0","endTime":"0","summary":"BioVie (BIVI) announced topline results from the company’s Phase 2 ADDRESS-LC trial evaluating its investigational drug candidate bezisterim, an or...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biovie-announces-topline-results-from-address-lc-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biovie-announces-topline-results-from-address-lc-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667737641","title":"BioVie Announces Topline Results from Phase 2 Address‑Lc Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long Covid","url":"https://stock-news.laohu8.com/highlight/detail?id=2667737641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667737641?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:30","pubTimestamp":1789471800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA71ZLNJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641760","title":"BioVie - 41.6% of Bezisterim Patients Experienced Adverse Events vs 55.9% for Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641760?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:30","pubTimestamp":1789471800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA71ZLNJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641754","title":"BioVie - Bezisterim Safety and Tolerability Profile Similar to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641754?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:30","pubTimestamp":1789471800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA71ZLNJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667064173","title":"BioVie - Bezisterim Shows Advantage over Placebo on 21 of 22 Endpoints in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667064173","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667064173?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:30","pubTimestamp":1789471800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA71ZLNJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioviepharma.com","stockEarnings":[{"period":"1week","weight":-0.0699},{"period":"1month","weight":-0.05},{"period":"3month","weight":0.3309},{"period":"6month","weight":-0.0952},{"period":"1year","weight":-0.1133},{"period":"ytd","weight":0.1466}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.005325},{"month":2,"riseRate":0.5,"avgChangeRate":0.259645},{"month":3,"riseRate":0.625,"avgChangeRate":-0.036628},{"month":4,"riseRate":0.375,"avgChangeRate":0.025089},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.110348},{"month":6,"riseRate":0.555556,"avgChangeRate":0.426902},{"month":7,"riseRate":0.444444,"avgChangeRate":0.260814},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.130957},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.181566},{"month":10,"riseRate":0.333333,"avgChangeRate":0.172375},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.012806},{"month":12,"riseRate":0.25,"avgChangeRate":-0.131533}],"exchange":"NASDAQ","name":"BioVie Inc","nameEN":"BioVie Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioVie Inc(BIVI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioVie Inc(BIVI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioVie Inc,BIVI,BioVie Inc股票,BioVie Inc股票老虎,BioVie Inc股票老虎国际,BioVie Inc行情,BioVie Inc股票行情,BioVie Inc股价,BioVie Inc股市,BioVie Inc股票价格,BioVie Inc股票交易,BioVie Inc股票购买,BioVie Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioVie Inc(BIVI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioVie Inc(BIVI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction